Feed excerpt — reported by STAT News
Medical mystery at AHA conference: Novartis drug pelacarsen lowered risk marker for cardiovascular disease but did not lower chance of heart attack, stroke.
MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →